Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

BACKGROUND: This study aimed to evaluate the efficacy, side-effects and resistance mechanisms of first-line afatinib in a real-world setting. METHODS: This is a multicenter observational study of first-line afatinib in Malaysian patients with epidermal growth factor receptor (EGFR)-mutant advanced n...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Gwo-Fuang, Chai, Chee-Shee, Alip, Adlinda, Wahid, Mohd Ibrahim A., Abdullah, Matin Mellor, Foo, Yoke-Ching, How, Soon-Hin, Zaatar, Adel, Lam, Kai-Seng, Leong, Kin-Wah, Low, John-Seng-Hooi, Yusof, Mastura Md, Lee, Erica Chai-Yong, Toh, Yok-Yong, Liam, Chong-Kin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734518/
https://www.ncbi.nlm.nih.gov/pubmed/31500587
http://dx.doi.org/10.1186/s12885-019-6107-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734518/
https://www.ncbi.nlm.nih.gov/pubmed/31500587
http://dx.doi.org/10.1186/s12885-019-6107-1

Ejemplares similares